Testosterone MD-Lotion Residual Washing Study (MTE11)

Acrux DDS

Status and phase: Completed; Phase 1

Conditions: Hypergonadism

Treatments: Drug: Testosterone MD-Lotion

Study type: Interventional

Funder types: Industry

Identifiers

NCT00996151

MTE11

Details and patient eligibility

About

The study will evaluate the amount of Testosteron MD-Lotion 2% remaining on the axilla after a single dose application in healthy males who undergo a post dose washing procedure.

Enrollment: 10 patients

Sex: Male

Ages: 18 to 70 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Healthy male subjects ≥18 and ≤ 70 years

Exclusion criteria

• Disqualifying concurrent condition or allergy/sensitivity to Testosterone MD-Lotion